Question
Amy Dyken, controller at Sweet Pharmaceutical Industries, a public company, is currently preparing the calculation for basic and diluted earnings per share and the related
Amy Dyken, controller at Sweet Pharmaceutical Industries, a public company, is currently preparing the calculation for basic and diluted earnings per share and the related disclosure for Sweets financial statements. Below is selected financial information for the fiscal year ended June 30, 2017.
SWEET PHARMACEUTICAL INDUSTRIES SELECTED BALANCE SHEET INFORMATION JUNE 30, 2017 | ||
Long-term debt | ||
Notes payable, 11% | $990,000 | |
7% convertible bonds payable | 5,080,000 | |
11% bonds payable | 6,120,000 | |
Total long-term debt | $12,190,000 | |
Shareholders equity | ||
Preferred stock, 6% cumulative, $50 par value, 95,000 shares authorized, 23,750 shares issued and outstanding | $1,187,500 | |
Common stock, $1 par, 10,000,000 shares authorized, 1,000,000 shares issued and outstanding | 1,000,000 | |
Additional paid-in capital | 3,920,000 | |
Retained earnings | 5,880,000 | |
Total shareholders equity | $11,987,500 |
The following transactions have also occurred at Sweet.
1. | Options were granted on July 1, 2016, to purchase 180,000 shares at $15 per share. Although no options were exercised during fiscal year 2017, the average price per common share during fiscal year 2017 was $20 per share. | |
2. | Each bond was issued at face value. The 7% convertible bonds will convert into common stock at 50 shares per $1,000 bond. The bonds are exercisable after 5 years and were issued in fiscal year 2016. | |
3. | The preferred stock was issued in 2016. | |
4. | There are no preferred dividends in arrears; however, preferred dividends were not declared in fiscal year 2017. | |
5. | The 1,000,000 shares of common stock were outstanding for the entire 2017 fiscal year. | |
6. | Net income for fiscal year 2017 was $1,500,000, and the average income tax rate is 40%. |
For the fiscal year ended June 30, 2017, calculate the following for Sweet Pharmaceutical Industries.
1) Basic Earnings Per Share
2) Diluted Earnings Per Share
Step by Step Solution
There are 3 Steps involved in it
Step: 1
Get Instant Access to Expert-Tailored Solutions
See step-by-step solutions with expert insights and AI powered tools for academic success
Step: 2
Step: 3
Ace Your Homework with AI
Get the answers you need in no time with our AI-driven, step-by-step assistance
Get Started